Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hedgehog Inhibition as a Non-Castrating Approach to Hormone Sensitive Prostate Cancer: A Phase II Study of Itraconazole in Biochemical Relapse

NCT01787331 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT01787331
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01787331 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hedgehog Inhibition as a Non-Castrating Approach to Hormone Sensitive Prostate Cancer: A Phase II Study of Itraconazole in Biochemical Relapse
Lead sponsor
University of California, San Francisco
Phase
Phase 2
Overall status
Completed
Start date
October 29, 2013
Completion date
September 30, 2018
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate adenocarcinoma, recurrent prostate carcinoma, stage i prostate adenocarcinoma ajcc v7, stage ii prostate adenocarcinoma ajcc v7, stage iii prostate adenocarcinoma ajcc v7